Likewise, Drachenberg et al (1999) reported high concentrations of IL-6 in men with hormone refractory prostate cancer compared to normal controls, benign prostatic hyperplasia, prostatitis and localised or recurrent disease. This evidence concerns the gene IL6 and urogenital neoplasm.